Compare SDST & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SDST | UG |
|---|---|---|
| Founded | 2022 | 1942 |
| Country | United States | United States |
| Employees | 8 | N/A |
| Industry | Blank Checks | Package Goods/Cosmetics |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.9M | 29.9M |
| IPO Year | N/A | 1995 |
| Metric | SDST | UG |
|---|---|---|
| Price | $2.78 | $6.61 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 76.9K | 3.7K |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 7.49% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.20 |
| Revenue | N/A | ★ $10,545,468.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $33.40 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.14 | $5.58 |
| 52 Week High | $7.67 | $9.88 |
| Indicator | SDST | UG |
|---|---|---|
| Relative Strength Index (RSI) | 46.63 | 53.82 |
| Support Level | $2.12 | $6.26 |
| Resistance Level | $3.00 | $6.80 |
| Average True Range (ATR) | 0.22 | 0.19 |
| MACD | 0.07 | 0.03 |
| Stochastic Oscillator | 82.61 | 70.51 |
Stardust Power Inc is developing a lithium refinery at its Facility in Muskogee, Oklahoma, with planned capacity of producing up to 50,000 metric tons per annum of BGLC once fully operational. The company will source lithium brine feedstock from various suppliers and may make investments upstream to secure additional feedstock. The Company seeks to sell its products to electric vehicle (EV) manufacturers as the primary market, with potential applications in other areas such as battery manufacturers, the U.S. military, and original equipment manufacturers (OEMs).
United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.